REAL-WORLD-DATA ON PLATINUM OUTCOMES AFTER PARP INHIBITORS PROGRESSION IN HIGH GRADE SEROUS OVARIAN CANCER PATIENTS

Por: Salarich, AP, Garcia, IT, Burdalo, BP, Gil-Martin, M, Rodriguez, JMP, Planas, CF, Ginesta, MPB, Valencia, AG, Gomez, AE and Marin, MR

---

Publicada: 1 dic 2020

---

---

Filiaciones:
Salarich, AP:
 Germans Trias & Pujol Univ Hosp Hugtip, Catalan Inst Oncol Ico Badalona, Badalona Appl Res Grp Oncol B Argo, Dept Med Oncol, Barcelona, Spain

:
 Germans Trias & Pujol Univ Hosp Hugtip, Catalan Inst Oncol Ico Badalona, Badalona Appl Res Grp Oncol B Argo, Dept Med Oncol, Barcelona, Spain

Burdalo, BP:
 Catalan Inst Oncol Ico Idibell, Dept Med Oncol, Lhospitalet De Llobregat, Spain

Gil-Martin, M:
 Catalan Inst Oncol Ico Idibell, Dept Med Oncol, Lhospitalet De Llobregat, Spain

Rodriguez, JMP:
 Catalan Inst Oncol Ico Idibell, Dept Med Oncol, Lhospitalet De Llobregat, Spain

Planas, CF:
 Girona Biomed Res Inst Idibgi, Catalan Inst Oncol Ico Girona, Dept Med Oncol, Girona, Spain

Ginesta, MPB:
 Girona Biomed Res Inst Idibgi, Catalan Inst Oncol Ico Girona, Dept Med Oncol, Girona, Spain

:
 Germans Trias & Pujol Univ Hosp Hugtip, Badalona Appl Res Grp Oncol BArgo, Catalan Inst Oncol Ico Badalona, Dept Stat, Barcelona, Spain

:
 Germans Trias & Pujol Univ Hosp Hugtip, Badalona Appl Res Grp Oncol BArgo, Catalan Inst Oncol Ico Badalona, Dept Stat, Barcelona, Spain

:
 Germans Trias & Pujol Univ Hosp Hugtip, Catalan Inst Oncol Ico Badalona, Badalona Appl Res Grp Oncol B Argo, Dept Med Oncol, Barcelona, Spain